Literature DB >> 1911787

Nucleotide-induced changes in the interaction of myosin subfragment 1 with actin: detection by antibodies against the N-terminal segment of actin.

G DasGupta1, E Reisler.   

Abstract

The binding of myosin subfragment 1 (S-1) to actin in the presence and absence of nucleotides was determined under conditions of partial saturation of actin, up to 80%, by Fab(1-7), the antibodies against the first seven N-terminal residues on actin. In the absence of nucleotides, the binding constant of S-1 to actin (2 x 10(7) M-1) was decreased by 1 order of magnitude by Fab(1-7). The binding of S-1 to actin caused only limited displacement of Fab, and between 30 and 50% of actin appeared to bind both proteins. In the presence of MgAMP.PNP, MgADP, and MgPPi and at low S-1 concentrations, the same antibodies caused a large decrease in the binding of S-1 to actin. However, the binding of S-1.nucleotide to actin in the presence of Fab(1-7) increased cooperatively with the increase in S-1 concentration. Also, in contrast to rigor conditions, there was no indication for the binding of Fab(1-7) and S-1.nucleotide to the same actin molecules. These results show a nucleotide-induced transition in the actomyosin interface, most likely related to the different roles of the N-terminal segment of actin in the binding of S-1 and S-1.nucleotide. The possible implications of these findings to the regulation of actomyosin interactions are discussed.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1911787     DOI: 10.1021/bi00105a021

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  9 in total

1.  Involvement of caldesmon at the actin-myosin interface.

Authors:  M C Harricane; E Fabbrizio; C Arpin; D Mornet
Journal:  Biochem J       Date:  1992-10-15       Impact factor: 3.857

2.  Small segmental rearrangements in the myosin head can explain force generation in muscle.

Authors:  F G Díaz Baños; J Bordas; J Lowy; A Svensson
Journal:  Biophys J       Date:  1996-08       Impact factor: 4.033

3.  Cross-bridge binding to actin and force generation in skinned fibers of the rabbit psoas muscle in the presence of antibody fragments against the N-terminus of actin.

Authors:  B Brenner; T Kraft; G DasGupta; E Reisler
Journal:  Biophys J       Date:  1996-01       Impact factor: 4.033

4.  Three-dimensional reconstruction of a co-complex of F-actin with antibody Fab fragments to actin's NH2 terminus.

Authors:  A Orlova; X Yu; E H Egelman
Journal:  Biophys J       Date:  1994-02       Impact factor: 4.033

5.  Myosin-induced changes in F-actin: fluorescence probing of subdomain 2 by dansyl ethylenediamine attached to Gln-41.

Authors:  E Kim; C J Miller; M Motoki; K Seguro; A Muhlrad; E Reisler
Journal:  Biophys J       Date:  1996-03       Impact factor: 4.033

6.  The N-terminal domains of myosin binding protein C can bind polymorphically to F-actin.

Authors:  Albina Orlova; Vitold E Galkin; Cy M J Jeffries; Edward H Egelman; Jill Trewhella
Journal:  J Mol Biol       Date:  2011-07-29       Impact factor: 5.469

7.  ATPase activity of myosin in hair bundles of the bullfrog's sacculus.

Authors:  S Burlacu; W D Tap; E A Lumpkin; A J Hudspeth
Journal:  Biophys J       Date:  1997-01       Impact factor: 4.033

8.  Proteome-derived peptide libraries allow detailed analysis of the substrate specificities of N(alpha)-acetyltransferases and point to hNaa10p as the post-translational actin N(alpha)-acetyltransferase.

Authors:  Petra Van Damme; Rune Evjenth; Håvard Foyn; Kimberly Demeyer; Pieter-Jan De Bock; Johan R Lillehaug; Joël Vandekerckhove; Thomas Arnesen; Kris Gevaert
Journal:  Mol Cell Proteomics       Date:  2011-03-07       Impact factor: 5.911

9.  The utrophin actin-binding domain binds F-actin in two different modes: implications for the spectrin superfamily of proteins.

Authors:  Vitold E Galkin; Albina Orlova; Margaret S VanLoock; Inna N Rybakova; James M Ervasti; Edward H Egelman
Journal:  J Cell Biol       Date:  2002-04-15       Impact factor: 10.539

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.